VOLITIONRX LTD Logo

VOLITIONRX LTD

Develops epigenetic blood tests for early cancer and sepsis detection in human/veterinary markets.

VNRX | US

Overview

Corporate Details

ISIN(s):
US9286611077
LEI:
Country:
United States of America
Address:
1489 WEST WARM SPRINGS ROAD, 89014 HENDERSON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

VolitionRx Ltd. is a multi-national epigenetics company that develops and commercializes blood-based diagnostic tests for the early detection and monitoring of life-altering diseases. The company's core technology is its proprietary Nu.Q® platform, a nucleosome quantification technology that detects epigenetic biomarkers in circulating chromatin. This platform enables the creation of simple, cost-effective, and non-invasive assays. Volition's primary applications are in oncology and sepsis for both the human and veterinary markets. The company's goal is to improve outcomes by enabling earlier diagnosis, monitoring disease progression, and evaluating treatment responses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all VOLITIONRX LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VOLITIONRX LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VOLITIONRX LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.
South Korea 355690
aTYR PHARMA INC Logo
Developing novel medicines for fibrosis and inflammation using tRNA synthetase biology.
United States of America ATYR
Aura Biosciences, Inc. Logo
Developing virus-like therapies to selectively destroy solid tumors in ocular & urologic oncology.
United States of America AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharma developing therapies for autoimmune and kidney diseases like lupus nephritis.
United States of America AUPH
AURORA CANNABIS INC Logo
A global producer and seller of medical and recreational cannabis and derivative products.
United States of America ACB
Autolus Therapeutics plc Logo
Develops programmed CAR T-cell therapies for cancer and autoimmune diseases.
United States of America AUTL
AVADEL PHARMACEUTICALS PLC Logo
Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.
United States of America AVDL
Avidity Biosciences, Inc. Logo
Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.
United States of America RNA
Axsome Therapeutics, Inc. Logo
Biopharma company developing novel therapies for central nervous system (CNS) conditions.
United States of America AXSM
AYTU BIOPHARMA, INC Logo
Specialty pharma advancing innovative medicines for CNS diseases like MDD and ADHD.
United States of America AYTU

Talk to a Data Expert

Have a question? We'll get back to you promptly.